71335-2221 Methotrexate - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

71335-2221

Brand Name:

Methotrexate

Generic Name:

Methotrexate

Dosage Form Name:

TABLET

Administration Route:

Oral

Substances:

Name: METHOTREXATE SODIUM

Strength: 2.5

Unit: mg/1

Packages:

Code: 71335-2221-01

Description: 30 TABLET in 1 BOTTLE (71335-2221-1)

Effective Date: Aug. 15, 2023

Discontinued:

Code: 71335-2221-02

Description: 12 TABLET in 1 BOTTLE (71335-2221-2)

Effective Date: Aug. 15, 2023

Discontinued:

Code: 71335-2221-03

Description: 20 TABLET in 1 BOTTLE (71335-2221-3)

Effective Date: Aug. 15, 2023

Discontinued:

Code: 71335-2221-04

Description: 100 TABLET in 1 BOTTLE (71335-2221-4)

Effective Date: Aug. 15, 2023

Discontinued:

Code: 71335-2221-05

Description: 36 TABLET in 1 BOTTLE (71335-2221-5)

Effective Date: Aug. 15, 2023

Discontinued:

Code: 71335-2221-06

Description: 24 TABLET in 1 BOTTLE (71335-2221-6)

Effective Date: Aug. 15, 2023

Discontinued:

Code: 71335-2221-07

Description: 90 TABLET in 1 BOTTLE (71335-2221-7)

Effective Date: Aug. 15, 2023

Discontinued:

Code: 71335-2221-08

Description: 4 TABLET in 1 BOTTLE (71335-2221-8)

Effective Date: Aug. 15, 2023

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Antimetabolite

Minor Class:

Folic Acid Analog

Orphan Drug Designation:

Status:

In Use